Indeed, several studies have shown that alterations in DNA damage response and repair genes are associated with response to programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) blockade in patients with several types of cancer [18, 19]. Here, PDCD1 is linked to cancer.